Company profile: Strateos
1.1 - Company Overview
Company description
- Provider of SaaS-based robotic solutions for biology labs, offering the Strateos Cloud Lab for remote experiment design, execution, and analysis; lab automation software to manage instruments and workflows via the cloud; design and build services for modular smart labs; AI for drug discovery; discovery biology services; and automated small molecule drug discovery workflows.
Products and services
- Strateos Cloud Lab: A cloud-based remote-controlled lab platform enabling scientists to architect, run, and analyze experiments from anywhere, facilitating drug discovery and synthetic biology workflows
- AI for Drug Discovery: An AI-driven platform that uses robotics to automate chemistry, biology, and tissue analysis, accelerating drug discovery programs
- Strateos Lab Automation Software: Cloud-native software that enables management and automation of research operations and instrumentation for executing scientific workflows via the cloud
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Strateos
TraceLink
HQ: United States
Website
- Description: Provider of a SaaS network creation platform that connects people, companies, systems, and processes to build integrated business ecosystems with multienterprise applications, enabling digitalization, customer-centric agility and resiliency across end-to-end supply networks and leveraging the collective intelligence of entire industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TraceLink company profile →
eMolecules
HQ: United States
Website
- Description: Provider of a free chemical structure search engine to search and order over 50M unique structures and 76M part numbers, including 4.5M building blocks and 20.3M screening compounds from 210+ suppliers. Offers compound reformatting, inventory management and global distribution, a virtual chemical space of over 4.9 trillion compounds for drug discovery, and structure data downloads for virtual screening, lead optimization, and cheminformatics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full eMolecules company profile →
TargetRx
HQ: United States
Website
- Description: Provider of unique insights for pharmaceutical and biotech companies into the true drivers of product choice and adoption for their brands, enabling confident actions to grow businesses and help patients, with a suite of solutions spanning from pipeline through patent expiry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TargetRx company profile →
Jungla
HQ: United States
Website
- Description: Provider of biotechnology solutions for clinical genetic and genomic testing, combining functional genomics, computational biophysics, and computer science. Offers the Molecular Evidence Platform, an active learning engine that integrates clinical knowledge to generate, evaluate, audit, and distribute evidence models, and solutions that augment and optimize clinical genetic and genomic test guidance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Jungla company profile →
Trials.ai
HQ: United States
Website
- Description: Provider of an AI-powered Smart Protocol system that optimizes clinical trial protocols and guides research teams in designing trials for speed and success, helping pharma, biotech, and device companies get treatments to patients faster.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Trials.ai company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Strateos
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Strateos
2.2 - Growth funds investing in similar companies to Strateos
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Strateos
4.2 - Public trading comparable groups for Strateos
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →